Allied BioScience
Plano, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
HC
Henry CrumptonDirector
KT
Keith TuckerChairman of the Board
VK
Vanessa KongDirector
AG
Alan GesselChief Operations Officer
BS
Bonnie SchmidtSenior Vice President, Human Resources
JK
Jennifer KeefeChief Legal Officer
DM
Daniel MorosDirector
ME
Maha El-SayedExecutive Officer
MS
Mohammed ShanablehDirector
TT
Tom TomesckoChief Customer Officer
MS
Michael S. RuleyChief Executive Officer and Director
JH
Jessica HiltonExecutive Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$3.7MraisedNov 2021 · 30 investors · BiotechnologyRule 506(b)
▶$3.7MraisedNov 2021 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bayard HollingsworthExecutive Officer
- Mohammed ShanablehDirector
- Bonnie SchmidtExecutive Officer
- Tom TomesckoExecutive Officer
- Henry A. CrumptonDirector
- Daniel MorosDirector
- Maha El-SayedExecutive Officer
- Jennifer KeefeExecutive Officer
- Offering amount
- $3.9M
- Amount sold
- $3.7M
- Minimum investment
- $5K
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$600KraisedOct 2021 · 6 investors · BiotechnologyRule 506(b)
▶$600KraisedOct 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Henry A. CrumptonDirector
- Daniel MorosDirector
- Maha El-SayedExecutive Officer
- Bayard HollingsworthExecutive Officer
- Bonnie SchmidtExecutive Officer
- Tom TomesckoExecutive Officer
- Mohammed ShanablehDirector
- Jennifer KeefeExecutive Officer
- David MaxwellExecutive Officer
- Offering amount
- $600K
- Amount sold
- $600K
- Minimum investment
- $50K
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$250KraisedMay 2021 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedMay 2021 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Henry A. CrumptonDirector
- Keith TuckerDirector
- Vanessa KongDirector
- Alan GesselExecutive Officer
- Bonnie SchmidtExecutive Officer
- Jennifer KeefeExecutive Officer
- Daniel MorosDirector
- Maha El-SayedExecutive Officer
- Mohammed ShanablehDirector
- Tom TomesckoExecutive Officer
- Michael S. RuleyExecutive Officer, Director
- Jessica HiltonExecutive Officer
- David MaxwellExecutive Officer
- Elias ShaheenExecutive Officer
- Offering amount
- $40M
- Amount sold
- $250K
- First sale
- May 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.3MofferedOct 2019 · BiotechnologyRule 506(b)
▶$6.3MofferedOct 2019 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dick RothkopfDirector
- Henry CrumptonDirector
- George PeatDirector
- Daniel MorosDirector
- Hugh DallasDirector
- Charles A. GeoffrionDirector
- Keith TuckerDirector
- Michael S RuleyExecutive Officer, Director
- Offering amount
- $6.3M
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$6.1MraisedMar 2019 · 48 investors · BiotechnologyRule 506(b)
▶$6.1MraisedMar 2019 · 48 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael S RuleyExecutive Officer
- Offering amount
- $12.5M
- Amount sold
- $6.1M
- First sale
- Feb 2018
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$5MofferedJul 2016 · BiotechnologyRule 506(b)
▶$5MofferedJul 2016 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael S. RuleyExecutive Officer
- Offering amount
- $5M
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.